Kairos Pharma KAPA
NYSE KAPA
$0.54 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Kairos Pharma (KAPA) Net Debt Issuances and Repayments (2024)

Updated

Analysis

Kairos Pharma (KAPA) Net Debt Issuances and Repayments (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -4.36 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -2.00 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 64.00 Mn
10 Kairos Pharma 11.24 Mn -1.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 40,000.00
API Access

Kairos Pharma Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=KAPA&period=max&api_key=YOUR_API_KEY